Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 1, Pages 77
Publisher
MDPI AG
Online
2019-01-11
DOI
10.3390/cancers11010077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fenofibrate inhibits mTOR-p70S6K signaling and simultaneously induces cell death in human prostate cancer cells
- (2018) Xin Lian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- mi R -27b and mi R -34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1
- (2018) Guangwei Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats
- (2018) Marwa M.M. Refaie et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- The Dualistic Origin of Human Tumors
- (2018) Jinsong Liu SEMINARS IN CANCER BIOLOGY
- Anticancer Properties of Fenofibrate: A Repurposing Use
- (2018) Xin Lian et al. Journal of Cancer
- Fenofibrate inhibits the growth of prostate cancer through regulating autophagy and endoplasmic reticulum stress
- (2018) Tao Tao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fenofibrate Interferes with the Diapedesis of Lung Adenocarcinoma Cells through the Interference with Cx43/EGF-Dependent Intercellular Signaling
- (2018) Katarzyna Piwowarczyk et al. Cancers
- Connexin43 high prostate cancer cells induce endothelial connexin43 up-regulation through the activation of intercellular ERK1/2-dependent signaling axis
- (2017) Katarzyna Piwowarczyk et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
- (2017) Karen Hanrahan et al. Molecular Oncology
- Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
- (2017) Jinglu Wang et al. Oncotarget
- Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?
- (2016) Qian Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells
- (2016) Kyle McIntosh et al. Expert Opinion on Drug Metabolism & Toxicology
- Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
- (2016) Luigi Ippolito et al. Oncotarget
- Sensitization to docetaxel in prostate cancer cells by green tea and quercetin
- (2015) Piwen Wang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Functional links between Snail-1 and Cx43 account for the recruitment of Cx43-positive cells into the invasive front of prostate cancer
- (2014) Damian Ryszawy et al. CARCINOGENESIS
- Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells
- (2014) Katarzyna Piwowarczyk et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cancer stem cells and tumor metastasis
- (2014) SHUANG LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Molecular Mechanisms of Fenofibrate-Induced Metabolic Catastrophe and Glioblastoma Cell Death
- (2014) Anna Wilk et al. MOLECULAR AND CELLULAR BIOLOGY
- Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
- (2014) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Triterpene saponosides from Lysimachia ciliata differentially attenuate invasive potential of prostate cancer cells
- (2013) Paulina Koczurkiewicz et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Peroxisome Proliferator Activated Receptor α Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism
- (2013) Maja Grabacka et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
- (2013) Nathan J. Robison et al. PEDIATRIC BLOOD & CANCER
- The roots of cancer: Stem cells and the basis for tumor heterogeneity
- (2012) Maho Shibata et al. BIOESSAYS
- EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
- (2012) Thomas Brabletz CANCER CELL
- Fenofibrate triggers apoptosis of glioblastoma cells in vitro
- (2012) Antonio Giordano et al. CELL CYCLE
- ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARα -mediated inhibition of Glioma cell motility in vitro
- (2012) Justyna Drukala et al. Molecular Cancer
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Exploring cancer stem cell niche directed tumor growth
- (2011) Andrea Sottoriva et al. CELL CYCLE
- Fenofibrate
- (2011) Kate McKeage et al. DRUGS
- Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms
- (2011) Daisuke Yamasaki et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
- (2011) Stephanie Alexander et al. TRENDS IN MOLECULAR MEDICINE
- On the Stem Cell Origin of Cancer
- (2010) Stewart Sell AMERICAN JOURNAL OF PATHOLOGY
- Gap junctions and connexins as therapeutic targets in cancer
- (2010) Mustapha Kandouz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cancer stem cells: problems for therapy?
- (2010) Malcolm R Alison et al. JOURNAL OF PATHOLOGY
- Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFα/NF-κB signaling axis
- (2010) Z Zak et al. LEUKEMIA
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
- (2009) Mark Shackleton et al. CELL
- Non-genetic heterogeneity — a mutation-independent driving force for the somatic evolution of tumours
- (2009) Amy Brock et al. NATURE REVIEWS GENETICS
- Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs
- (2009) Catherine Sánchez et al. PROSTATE
- PPARs: A Double-Edged Sword in Cancer Therapy?
- (2009) Dipak Panigrahy et al. PPAR Research
- Prostate Cancer Stem Cells: A New Target for Therapy
- (2008) Norman J. Maitland et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer stem cells
- (2008) SH Lang et al. JOURNAL OF PATHOLOGY
- PPAR agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
- (2008) D. Panigrahy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anticancer Properties of PPARα-Effects on Cellular Metabolism and Inflammation
- (2008) Maja Grabacka et al. PPAR Research
- Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
- (2008) Roberto Scatena et al. PPAR Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started